Jinling Pharmaceutical Company Limited (000919.SZ)
CNY 6.91
(-1.14%)
CNY 6.91
(-1.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.78 Billion | 2.67 Billion | 2.8 Billion | 2.5 Billion | 2.53 Billion | 2.89 Billion |
| Cost of Revenue | 2.19 Billion | 2.14 Billion | 2.17 Billion | 1.94 Billion | 1.93 Billion | 2.2 Billion |
| Gross Profit | 586.11 Million | 528.14 Million | 630.07 Million | 561.39 Million | 598.18 Million | 696.32 Million |
| Operating Expenses | 469.11 Million | 465.66 Million | 453.41 Million | 379.8 Million | 400.95 Million | 487.23 Million |
| Selling, General and Administrative Expenses | 169.34 Million | 160.25 Million | 172.6 Million | 147.24 Million | 144.15 Million | 239.03 Million |
| Research and Development Expenses | 79.14 Million | 74.17 Million | 57.01 Million | 43.7 Million | 43.91 Million | 34.12 Million |
| Other Expenses | -316.85 Thousand | 231.23 Million | 223.79 Million | 188.85 Million | 212.88 Million | -2.28 Million |
| Cost and Expenses | 2.66 Billion | 2.6 Billion | 2.63 Billion | 2.32 Billion | 2.33 Billion | 2.68 Billion |
| Operating Income | 116.99 Million | 94.64 Million | 197.17 Million | 180.36 Million | 340.4 Million | 363.82 Million |
| Interest Expense | 1.36 Million | 255.67 Thousand | 292.62 Thousand | 383.54 Thousand | 426.18 Thousand | 2.64 Million |
| Income Tax Expense | 11.23 Million | 13.9 Million | 41.87 Million | 31.46 Million | 63.73 Million | 72.66 Million |
| Earnings before Tax | 118.42 Million | 127.77 Million | 194.81 Million | 125.12 Million | 247.41 Million | 361.54 Million |
| Net Income | 99.65 Million | 105.28 Million | 120.62 Million | 93.65 Million | 145.31 Million | 241.78 Million |
| Earnings Per Share Basic | 0.20 | 0.21 | 0.24 | 0.19 | 0.29 | 0.48 |
| Earnings Per Share Diluted | 0.20 | 0.21 | 0.24 | 0.19 | 0.29 | 0.48 |
| Weighted Average Shares Outstanding | 504 Million | 504 Million | 504 Million | 504 Million | 504 Million | 504 Million |
| Weighted Average Shares Outstanding (Diluted) | 504 Million | 504 Million | 504 Million | 504 Million | 504 Million | 504.03 Million |
| Gross Margin | 0.21 | 0.20 | 0.22 | 0.22 | 0.24 | 0.24 |
| EBIT Margin | 0.09 | 0.08 | 0.11 | 0.12 | 0.18 | 0.17 |
| Profit Margin | 0.04 | 0.04 | 0.04 | 0.04 | 0.06 | 0.08 |
| EBITDA | 249.63 Million | 254.72 Million | 325.5 Million | 236.41 Million | 312.76 Million | 483.61 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.07 | 0.07 | 0.13 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 709.28 Million | 758.73 Million | 746.52 Million | 2.78 Billion | 681.49 Million | 662.84 Million |
| Cost of Revenue | 576.28 Million | 626.04 Million | 576.63 Million | 2.19 Billion | 544.65 Million | 525.99 Million |
| Gross Profit | 133 Million | 132.69 Million | 169.89 Million | 586.11 Million | 136.83 Million | 136.85 Million |
| Operating Expenses | 138.48 Million | 115.2 Million | 110.99 Million | 506.26 Million | 156.35 Million | 125.16 Million |
| Selling, General and Administrative Expenses | 243.96 Million | 98.98 Million | 87.71 Million | - | -134.38 Million | 229.83 Million |
| Research and Development Expenses | 26.77 Million | 16.22 Million | 20.77 Million | - | 36.94 Million | 14.56 Million |
| Other Expenses | -132.25 Million | 71.09 Thousand | 214.31 Thousand | 1.42 Million | 1.19 Million | 395.75 Thousand |
| Cost and Expenses | 714.76 Million | 741.24 Million | 687.62 Million | 2.7 Billion | 701.01 Million | 651.15 Million |
| Operating Income | 19.55 Million | 17.48 Million | 60.94 Million | 116.99 Million | -6.35 Million | 24.17 Million |
| Interest Expense | 14.13 Thousand | 23.48 Thousand | 21.92 Thousand | 230.95 Thousand | 89.14 Thousand | 43.74 Thousand |
| Income Tax Expense | 4.36 Million | 1.87 Million | 13.98 Million | 11.23 Million | -5.44 Million | 2.6 Million |
| Earnings before Tax | 20.24 Million | 29.47 Million | 61.15 Million | 118.42 Million | -5.16 Million | 24.56 Million |
| Net Income | 19.54 Million | 8.27 Million | 43.54 Million | 99.65 Million | 2.04 Million | 20.08 Million |
| Earnings Per Share Basic | 0.03 | 0.01 | 0.08 | - | 0.00 | 0.04 |
| Earnings Per Share Diluted | 0.03 | 0.01 | 0.08 | - | 0.00 | 0.04 |
| Weighted Average Shares Outstanding | 621.92 Million | 621.92 Million | 512.89 Million | 504.05 Million | 504.58 Million | 504 Million |
| Weighted Average Shares Outstanding (Diluted) | 621.92 Million | 621.92 Million | 512.89 Million | 504.05 Million | 504.46 Million | 504 Million |
| Gross Margin | 0.19 | 0.17 | 0.23 | 0.21 | 0.20 | 0.21 |
| EBIT Margin | 0.03 | 0.07 | 0.09 | - | -0.01 | 0.04 |
| Profit Margin | 0.03 | 0.01 | 0.06 | 0.04 | 0.00 | 0.03 |
| EBITDA | 20.26 Million | 52.77 Million | 63.67 Million | - | -8.04 Million | 26.9 Million |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.08 | 0.04 | -0.01 | 0.04 |
2930
SJCORP
ECS
LUM
000753
EIHOTEL